Evaluation of ceftazidime/avibactam for treatment of carbapenemase-producing carbapenem-resistant Enterobacterales with OXA-48 and/or NDM genes with or without combination therapy

BACKGROUND: Carbapenem-resistant Enterobacterales (CRE) is an urgent public health threat of significant global concern. Few observational studies have evaluated the clinical outcomes for treatment of CRE harbouring OXA-48 or NDM genes with ceftazidime/avibactam. Previous findings showed lower 30 da...

Descripción completa

Detalles Bibliográficos
Autores principales: Alqahtani, Hajar, Alghamdi, Ahlam, Alobaidallah, Nouf, Alfayez, Amal, Almousa, Rawan, Albagli, Rawan, Shamas, Nour, Farahat, Fayssal, Mahmoud, Ebrahim, Bosaeed, Mohammad, Abanamy, Reem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552550/
https://www.ncbi.nlm.nih.gov/pubmed/36237571
http://dx.doi.org/10.1093/jacamr/dlac104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552550/
https://www.ncbi.nlm.nih.gov/pubmed/36237571
http://dx.doi.org/10.1093/jacamr/dlac104

Ejemplares similares